A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma

Launched by BEIJING FRIENDSHIP HOSPITAL · Jul 19, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the factors that may influence the recurrence of papillary thyroid carcinoma (PTC) after a treatment called thermal ablation. Thermal ablation is a procedure that uses heat to destroy cancer cells in the thyroid. The researchers are gathering various information from patients who have undergone this treatment, including their health data, ultrasound results, and questionnaires about their experiences with fatigue, depression, and stress. The goal is to understand what might lead to the cancer coming back after treatment.

To participate in this trial, you need to be at least 18 years old and have a specific type of thyroid nodule that is small and has not spread to nearby lymph nodes. You also need to be able to give informed consent, which means you understand the study and its risks. Participants will be closely monitored and asked to complete surveys about their health and well-being. This research is important as it aims to improve our understanding of PTC and how to better manage it after thermal ablation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ①≥18 years old; ② Obtain informed consent; ③ Ultrasonography showed that malignant nodules were single, the maximum diameter of nodules was ≤1cm and the distance from the capsule was ≥2mm. ④ no lymph node metastasis or other extra-glandular metastasis in the neck; ⑤ PTC was confirmed by fine needle puncture pathology; ⑥ Patients who do not meet Article 3, who still strongly request thermal ablation while fully informing the patient of the risk of recurrence, and who have been clinically assessed to be technically capable of thermal ablation Exclusion Criteria:① Pregnant or lactating patients; ② Patients with other malignant tumors and not suitable for ablation by clinical evaluation; ③ Patients who cannot tolerate surgery; ④ Patients with cognitive impairment and other conditions who cannot accurately fill in thyroid-related questionnaires.